$356.59
3.801.08%
Last update: Aug 20, 12:14 PM
West Pharmaceutical Services Inc
WSTNYSE
West Pharmaceutical Servs Earnings & Forecasts
West Pharmaceutical Servs (WST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
West Pharmaceutical Servs Guidance
West Pharmaceutical Servs (WST) last issued guidance on July 23, 2026 for fiscal year 2026. The company guided earnings per share in the range of $8.85 - $9.05, compared to a consensus EPS estimate of $8.61. West Pharmaceutical Servs also guided revenue in the range of $3.35B - $3.38B for the period.
Compared to prior guidance, West Pharmaceutical Servs raised its EPS outlook from a previous range of $8.4 - $8.75. On the revenue side, the company raised its revenue forecast from a prior range of $3.29B - $3.35B.
West Pharmaceutical Servs has issued 18 guidance updates between October 27, 2022 and July 23, 2026. During this period, the company raised its outlook 13 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.08 | $1.68 | $1.83 | $1.68 |
| Actual | $2.37 | $2.13 | $2.04 | $1.96 |
| Surprise | +13.9% | +26.8% | +11.5% | +16.7% |
| Revenue | ||||
| Estimate | $838.0M | $779.2M | $794.6M | $786.8M |
| Actual | $872.3M | $844.9M | $805.0M | $804.6M |
| Surprise | +4.09% | +8.44% | +1.31% | +2.26% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.19 | $2.27 | $2.27 | $2.53 |
| Revenue | ||||
| Consensus | $826.0M | $827.8M | — | — |
